A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients

Short-term and perspective results

M. C. Mauri, A. Ferrara, L. Fabiano, C. Ricci, G. Invernizzi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Twenty-six HIV positive patients were included in the study. Sixteen patients were treated with fluvoxamine 100-150 mg/die p.o. t.i.d. and 10 patients were treated with placebo for 8 weeks under double-blind conditions. Patients treated with fluvoxamine showed a significant HAM-D improvement (p <0.01). Eleven of the 26 patients died within a year of the end of the trial. They showed a higher T0 and T8 HAM-D total score compared to the surviving patients with a significantly higher T8 HAM-D score (p <0.01) in patients treated with placebo.

Original languageEnglish
Pages (from-to)199-201
Number of pages3
JournalIntegrative Psychiatry
Volume10
Issue number4
Publication statusPublished - 1994

Fingerprint

Fluvoxamine
Double-Blind Method
Placebos
HIV

Keywords

  • Fluvoxamine
  • HIV+ patients

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients : Short-term and perspective results. / Mauri, M. C.; Ferrara, A.; Fabiano, L.; Ricci, C.; Invernizzi, G.

In: Integrative Psychiatry, Vol. 10, No. 4, 1994, p. 199-201.

Research output: Contribution to journalArticle

Mauri, M. C. ; Ferrara, A. ; Fabiano, L. ; Ricci, C. ; Invernizzi, G. / A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients : Short-term and perspective results. In: Integrative Psychiatry. 1994 ; Vol. 10, No. 4. pp. 199-201.
@article{49f1f13950da4db18d548c8bfa988114,
title = "A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients: Short-term and perspective results",
abstract = "Twenty-six HIV positive patients were included in the study. Sixteen patients were treated with fluvoxamine 100-150 mg/die p.o. t.i.d. and 10 patients were treated with placebo for 8 weeks under double-blind conditions. Patients treated with fluvoxamine showed a significant HAM-D improvement (p <0.01). Eleven of the 26 patients died within a year of the end of the trial. They showed a higher T0 and T8 HAM-D total score compared to the surviving patients with a significantly higher T8 HAM-D score (p <0.01) in patients treated with placebo.",
keywords = "Fluvoxamine, HIV+ patients",
author = "Mauri, {M. C.} and A. Ferrara and L. Fabiano and C. Ricci and G. Invernizzi",
year = "1994",
language = "English",
volume = "10",
pages = "199--201",
journal = "Integrative Psychiatry",
issn = "0735-3847",
number = "4",

}

TY - JOUR

T1 - A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients

T2 - Short-term and perspective results

AU - Mauri, M. C.

AU - Ferrara, A.

AU - Fabiano, L.

AU - Ricci, C.

AU - Invernizzi, G.

PY - 1994

Y1 - 1994

N2 - Twenty-six HIV positive patients were included in the study. Sixteen patients were treated with fluvoxamine 100-150 mg/die p.o. t.i.d. and 10 patients were treated with placebo for 8 weeks under double-blind conditions. Patients treated with fluvoxamine showed a significant HAM-D improvement (p <0.01). Eleven of the 26 patients died within a year of the end of the trial. They showed a higher T0 and T8 HAM-D total score compared to the surviving patients with a significantly higher T8 HAM-D score (p <0.01) in patients treated with placebo.

AB - Twenty-six HIV positive patients were included in the study. Sixteen patients were treated with fluvoxamine 100-150 mg/die p.o. t.i.d. and 10 patients were treated with placebo for 8 weeks under double-blind conditions. Patients treated with fluvoxamine showed a significant HAM-D improvement (p <0.01). Eleven of the 26 patients died within a year of the end of the trial. They showed a higher T0 and T8 HAM-D total score compared to the surviving patients with a significantly higher T8 HAM-D score (p <0.01) in patients treated with placebo.

KW - Fluvoxamine

KW - HIV+ patients

UR - http://www.scopus.com/inward/record.url?scp=0028678492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028678492&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 199

EP - 201

JO - Integrative Psychiatry

JF - Integrative Psychiatry

SN - 0735-3847

IS - 4

ER -